Mar 5, 2025 · Library of Congress
Introduced in House
Status: In committee
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Sponsored by Neal P. Dunn (Republican-FL-2)
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.